• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

三尖瓣边缘对边缘修复术后经导管三尖瓣置换术

Transcatheter Tricuspid Valve Replacement Following Tricuspid Edge-To-Edge-Repair.

作者信息

Goldschmied Andreas, Droppa Michal, Gawaz Meinrad, Geisler Tobias

机构信息

Department of Cardiology and Angiology, University Hospital Tübingen, Otfried-Müller-Straße 10, Tübingen, Baden-Württemberg, Germany.

出版信息

Catheter Cardiovasc Interv. 2025 Jan;105(1):265-269. doi: 10.1002/ccd.31317. Epub 2024 Dec 2.

DOI:10.1002/ccd.31317
PMID:39623673
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11694554/
Abstract

Significant tricuspid regurgitation (TR) is seen as a relevant contributor of cardiac morbidity and mortality. Transcatheter tricuspid valve replacement (TTVR) is a novel technique to treat this condition. We present the case of an 82-year-old lady who was admitted for recurrent right heart decompensation despite having undergone treatment with tricuspid edge-to-edge repair (TEER). The patient underwent transfemoral implantation of a 48 mm EVOQUE valve. Since the implanted Clip was not in the central part of the valve, it was pushed toward the valvular anulus by the expanded prothesis. Echocardiography showed a good result with no residual TR. Options for residual TR after T-TEER are very limited. TTVR might be suitable in selected patients with non-central Clip placement.

摘要

严重三尖瓣反流（TR）被视为心脏发病和死亡的一个相关因素。经导管三尖瓣置换术（TTVR）是治疗这种疾病的一种新技术。我们报告一例82岁女性病例，尽管已接受三尖瓣缘对缘修复术（TEER）治疗，但仍因反复出现右心功能不全而入院。该患者接受了经股动脉植入48毫米EVOQUE瓣膜。由于植入的夹子不在瓣膜的中央部分，它被扩张的假体推向瓣膜环。超声心动图显示结果良好，无残余TR。T-TEER术后残余TR的治疗选择非常有限。TTVR可能适用于夹子放置不在中央的特定患者。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb7d/11694554/836af15a51a0/CCD-105-265-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb7d/11694554/1909277d934a/CCD-105-265-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb7d/11694554/c38a75ad07c4/CCD-105-265-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb7d/11694554/ae5e8dd18723/CCD-105-265-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb7d/11694554/51cadbaca0cd/CCD-105-265-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb7d/11694554/665aedfe1b8c/CCD-105-265-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb7d/11694554/f5b0cd17456f/CCD-105-265-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb7d/11694554/836af15a51a0/CCD-105-265-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb7d/11694554/1909277d934a/CCD-105-265-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb7d/11694554/c38a75ad07c4/CCD-105-265-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb7d/11694554/ae5e8dd18723/CCD-105-265-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb7d/11694554/51cadbaca0cd/CCD-105-265-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb7d/11694554/665aedfe1b8c/CCD-105-265-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb7d/11694554/f5b0cd17456f/CCD-105-265-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb7d/11694554/836af15a51a0/CCD-105-265-g001.jpg

相似文献

1
Transcatheter Tricuspid Valve Replacement Following Tricuspid Edge-To-Edge-Repair.三尖瓣边缘对边缘修复术后经导管三尖瓣置换术
Catheter Cardiovasc Interv. 2025 Jan;105(1):265-269. doi: 10.1002/ccd.31317. Epub 2024 Dec 2.
2
Eligibility for Transcatheter Tricuspid Valve Interventions in Patients With Tricuspid Regurgitation.三尖瓣反流患者经导管三尖瓣介入治疗的适应证
JACC Cardiovasc Interv. 2024 Dec 9;17(23):2732-2744. doi: 10.1016/j.jcin.2024.09.019.
3
Predictors of Procedural and Clinical Outcomes in Patients With Symptomatic Tricuspid Regurgitation Undergoing Transcatheter Edge-to-Edge Repair.经导管缘对缘修复术治疗症状性三尖瓣反流患者的操作和临床结局的预测因素。
JACC Cardiovasc Interv. 2018 Jun 25;11(12):1119-1128. doi: 10.1016/j.jcin.2018.05.002.
4
Transfemoral Transcatheter Tricuspid Valve Replacement.经股动脉经导管三尖瓣置换术
JACC Cardiovasc Interv. 2020 May 25;13(10):e93-e94. doi: 10.1016/j.jcin.2020.01.194. Epub 2020 Mar 11.
5
Early Single-Site Experience With Transcatheter Tricuspid Valve Replacement.经导管三尖瓣置换的早期单部位经验。
JACC Cardiovasc Imaging. 2019 Mar;12(3):416-429. doi: 10.1016/j.jcmg.2018.08.034. Epub 2018 Dec 12.
6
Long-Term Outcomes of the FORMA Transcatheter Tricuspid Valve Repair System for the Treatment of Severe Tricuspid Regurgitation: Insights From the First-in-Human Experience.经导管三尖瓣修复系统治疗重度三尖瓣反流的长期结果：首例人体经验的见解。
JACC Cardiovasc Interv. 2019 Aug 12;12(15):1438-1447. doi: 10.1016/j.jcin.2019.04.038.
7
Comparative analysis of MitraClip/TriClip and PASCAL in transcatheter tricuspid valve repair for tricuspid regurgitation: a systematic review and meta-analysis.经导管三尖瓣修复术治疗三尖瓣反流的 MitraClip/TriClip 和 PASCAL 的对比分析：系统评价和荟萃分析。
BMC Cardiovasc Disord. 2024 Oct 14;24(1):557. doi: 10.1186/s12872-024-04201-6.
8
Transcatheter Edge-to-Edge Repair in Patients With Complex Tricuspid Valve Anatomy.复杂三尖瓣解剖结构患者的经导管缘对缘修复术
JACC Cardiovasc Interv. 2024 Dec 9;17(23):2749-2760. doi: 10.1016/j.jcin.2024.08.035.
9
Transjugular Transcatheter Tricuspid Valve Replacement: Early Compassionate Use Outcomes.经颈静脉经导管三尖瓣置换术：早期同情使用结果。
JACC Cardiovasc Interv. 2024 Aug 26;17(16):1936-1945. doi: 10.1016/j.jcin.2024.06.014.
10
1-Year Outcomes After Edge-to-Edge Valve Repair for Symptomatic Tricuspid Regurgitation: Results From the TriValve Registry.Edge-to-Edge 瓣叶修复术治疗症状性三尖瓣反流的 1 年结果：TriValve 注册研究结果。
JACC Cardiovasc Interv. 2019 Aug 12;12(15):1451-1461. doi: 10.1016/j.jcin.2019.04.019.

本文引用的文献

1
Quality of Life After Transcatheter Tricuspid Valve Replacement: 1-Year Results From TRISCEND II Pivotal Trial.经导管三尖瓣置换术后的生活质量：TRISCEND II 关键试验的 1 年结果
J Am Coll Cardiol. 2025 Jan 28;85(3):206-216. doi: 10.1016/j.jacc.2024.10.067. Epub 2024 Oct 30.
2
3D Navigation and Intraprocedural Intracardiac Echocardiography Imaging for Tricuspid Transcatheter Edge-to-Edge Repair.用于三尖瓣经导管缘对缘修复的3D导航和术中心内超声心动图成像
JACC Cardiovasc Imaging. 2024 Apr;17(4):441-447. doi: 10.1016/j.jcmg.2024.02.005.
3
Antithrombotic Treatment After Transcatheter Valve Interventions: Current Status and Future Directions.
经导管瓣膜介入治疗后的抗血栓治疗：现状与未来方向。
Clin Ther. 2024 Feb;46(2):122-133. doi: 10.1016/j.clinthera.2023.09.028. Epub 2023 Nov 4.
4
vICE-Guided T-TEER in a Patient Without TEE Windows.无经食管超声心动图（TEE）透声窗患者的ICE引导经导管缘对缘修复术（T-TEER）
JACC Cardiovasc Interv. 2022 Dec 26;15(24):e245-e247. doi: 10.1016/j.jcin.2022.08.056. Epub 2022 Nov 30.
5
6-Month Outcomes of the TricValve System in Patients With Tricuspid Regurgitation: The TRICUS EURO Study.三尖瓣系统治疗三尖瓣反流患者的 6 个月结果：TRICUS EURO 研究。
JACC Cardiovasc Interv. 2022 Jul 11;15(13):1366-1377. doi: 10.1016/j.jcin.2022.05.022. Epub 2022 May 17.
6
Transfemoral Tricuspid Valve Replacement in Patients With Tricuspid Regurgitation: TRISCEND Study 30-Day Results.经股三尖瓣置换术治疗三尖瓣反流患者：TRISCEND 研究 30 天结果。
JACC Cardiovasc Interv. 2022 Mar 14;15(5):471-480. doi: 10.1016/j.jcin.2022.01.016.
7
Transfemoral transcatheter tricuspid valve replacement after failed leaflet repair.瓣叶修复失败后经股动脉导管三尖瓣置换术
EuroIntervention. 2021 Dec 17;17(12):e1022-1023. doi: 10.4244/EIJ-D-21-00614.
8
First-in-Human Percutaneous Circumferential Annuloplasty for Secondary Tricuspid Regurgitation.首例用于继发性三尖瓣反流的经皮环周瓣环成形术人体试验
JACC Case Rep. 2020 Nov 18;2(14):2176-2182. doi: 10.1016/j.jaccas.2020.08.032.
9
Transcatheter edge-to-edge repair for reduction of tricuspid regurgitation: 6-month outcomes of the TRILUMINATE single-arm study.经导管缘对缘修复术减少三尖瓣反流：TRILUMINATE 单臂研究的 6 个月结果。
Lancet. 2019 Nov 30;394(10213):2002-2011. doi: 10.1016/S0140-6736(19)32600-5. Epub 2019 Nov 7.